Patent ID: 8700335
Filing Date: 2014-04-15
Classification: C12Q,G01N,G16B,G16H

Abstract:
1. A method for determining a personalized medical intervention for an individual having a diagnosed pancreatic cancer comprising the steps of: a) measuring a gene and/or a protein expression level of each of ERBB2, ESR1, PGR, KIT, EGFR, PTGS2 and AR in one or more sample of the individual's pancreatic cancer; b) comparing the expression levels of the genes and/or proteins measured in step a) to a reference; c) accessing a computer database to identify at least one drug therapy that interacts with each of the genes and/or proteins that exhibited a change in expression as compared to the reference in step b); and d) providing a computer generated report that identifies the at least one drug therapy identified in step c).